What Happened
Top brokerage firms have identified Gland Pharma and Star Cement, among others, as stocks with potential for 10-30% returns in 2026 for long-term investors. These recommendations are based on their research and analysis.
Why It Matters (for you)
Brokerage recommendations can influence investor sentiment and capital allocation, especially for long-term portfolios. Such endorsements suggest underlying fundamental strength or growth prospects in these companies and their respective sectors.
Impact on Indian Markets
Gland Pharma (pharmaceuticals) and Star Cement (cement/construction materials) could see increased buying interest from long-term investors. This could lead to gradual price appreciation as more investors act on these recommendations. The pharma and infrastructure sectors might also see renewed interest.
What Traders Should Watch Next
Long-term investors should conduct their own due diligence on these stocks, focusing on their financial performance, growth drivers, and competitive landscape. Monitor quarterly results and any significant company-specific news that could impact these projections.
Key Evidence
- Gland Pharma, Star Cement among 5 stocks recommended for long term.
- Brokerage firms project 10-30% return in 2026.
- Recommendations collated from ETNow and other sources.
- Risk flag: Broader market downturns affecting all stocks
- Risk flag: Company-specific underperformance or negative news